Phyllis Schreiner
Internal Medicine · Rockville, MDNPI 1972561512
Payments from drug & device makers
Across 79 payments — averaging $15.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$176
- AbbVie$142
- Pfizer$123
- Amgen$103
- Lilly USA, LLC$103
- Novo Nordisk$90
- plus $462 from 17 others
What the payments were for
- Food & beverage$1,199100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 15 | $176 |
| AbbVie(2 entities) | 9 | $142 |
| Pfizer | 9 | $123 |
| Amgen | 6 | $103 |
| Lilly USA, LLC | 6 | $103 |
| Novo Nordisk | 6 | $90 |
| AstraZeneca | 5 | $71 |
| Daiichi Sankyo Inc. | 4 | $70 |
| Amarin Pharma, Inc. | 3 | $49 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 2 | $23 |
| GSK | 1 | $21 |
| Sanofi | 1 | $21 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| Boston Scientific | 1 | $16 |
| Corcept Therapeutics | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| Novartis | 1 | $13 |
| Boehringer Ingelheim | 1 | $12 |
| Endo Pharmaceuticals Inc. | 1 | $11 |
How this compares
$1,199 in reported general payments places this provider in the 75th percentile of 2,979 internal medicine providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SynthroidLevothyroxine Sodium | 33 | $3,921 |
| Atorvastatin Calcium | 99 | $1,295 |
| Levothyroxine Sodium | 53 | $653 |
| Metoprolol Succinate | 17 | $444 |
| Losartan Potassium | 44 | $440 |
| Amlodipine Besylate | 47 | $427 |
| Irbesartan | 20 | $425 |
| Sertraline Hcl | 25 | $421 |
| Escitalopram Oxalate | 18 | $403 |
| Pravastatin Sodium | 22 | $401 |
| Famotidine | 14 | $353 |
| Lisinopril | 29 | $334 |
| Simvastatin | 35 | $330 |
| Rosuvastatin Calcium | 18 | $285 |
| Pantoprazole Sodium | 16 | $245 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $142 | $3,92133 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,979 internal medicine providers in Maryland.
Other internal medicine in Rockville
- Shishir KhetanRockville$52.1M
- Jonathan CohenRockville$5M
- Rahul PatelRockville$2.8M
- Alan PollackRockville$2.1M
- Ravi PassiRockville$1.6M
- Padmaja MuthiahRockville$302K
- Ira BergerRockville$228K
- Michael SauriRockville$214K
- David CharlesRockville$171K
- Steven GellerElkridge$15.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.